Find in Library

674 A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy in 3L and in combination with pembrolizumab in 1L recurrent/metastatic HPV16+ head and neck cancer patients

oleh: Faye Johnson, Nashat Gabrail, Ammar Sukari, Barbara Burtness, Christine H Chung, Sara Pai, Lara A Dunn, Cristina Rodriguez, Marya Chaney, Apollina Goel, Ricklie Julian, Francis Worden, Rami Haddad, Douglas Adkins, A Dimitrios Colevas, Laura Agensky, Matteo Levisetti, Steven Margossian, Steve Quayle, Jong Chul Park, Robert M Jotte, Tanguy Y Seiwert, Nabil F Saba, Julie E Bauman, Michael K Gibson